Health IT companies across revenue cycle management, behavioral health, cybersecurity, supply chain and other areas highlight new developments and share how they have responded to the challenges of the Covid-19 pandemic.
How has thinking around cybersecurity in healthcare evolved, and what challenges remain? How is the healthcare industry facing down cybersecurity threats internally and externally?
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
A look at some of the developments that have helped telehealth and telemedicine evolve, including policy issues, collaboration deals and some of the players in virtual care.
This eBook offers an overview of drug patents that were and are set to expire and highlights efforts by the FDA to stimulate the market for generics.
Digitizing and automating what can be an inefficient process is the kind of low-hanging fruit that many startups target. Revenue cycle management offers fertile ground for those purposes.
From a new treatment for sickle cell disease to supersized acquisitions, some of the biggest stories in 2019 set the stage for the new year.
Alan Murray on improving access for medical transportation.
Our latest eBook offers examples of how some of the players in healthcare are thinking about AI, seeking to apply it across care coordination, drug development and early detection of disease and how to address some of the challenges the technology poses for adoption and implementation.
A new eBook from MedCity News spotlights some of the more interesting deals and trends this year across digital health and biopharma.
A new eBook from MedCity News explores different approaches to clinical trial design such as how technology could support remote monitoring for clinical trials and how pharma companies can improve clinical trial diversity.
A new eBook explores the different ways public and private insurers are moving the needle forward to integrate and cover innovative technologies.
CEO and neuroscientist Dr. Iftach Dolev on how the new device can bring a powerful tool to psychiatrists and neurologists alike.